PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

57 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Velkov, S. ; Protzer, U. & Michler, T.: Approximation of the genotype distribution within global chronic hepatitis B virus infections. J. Hepatol. 70, E711-E711 (2019)
22.
Wilman, H.R.* et al.: Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration. J. Hepatol. 71, 594-602 (2019)
23.
Einer, C. ; Leitzinger, C. ; Hohenester, S.* ; Weiss, K.H.* & Zischka, H.: High caloric nutrition promotes hepatocellular damage and steatohepatitis in Wilson disease rats via amplified mitochondrial damage. J. Hepatol. 68, S626-S626 (2018)
24.
Ko, C. et al.: Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. J. Hepatol. 69, 1231-1241 (2018)
25.
Michler, T. et al.: Combinatorial RNAi/vaccination therapy for chronic hepatitis B achieves long-term functional cure in preclinical mouse model. J. Hepatol. 68, S16-S16 (2018)
26.
van de Klundert, M. ; Ringelhan, M. & Protzer, U.: Statins suppress hepatitis B virus replication and reduce hepatoma cell viability by interfering with Rho-GTPases. J. Hepatol. 68, S782-S782 (2018)
27.
Wisskirchen, K. et al.: T cells grafted with HBV-specific T-cell receptors of high functional avidity achieve functional cure of HBV infection in humanized mice. J. Hepatol. 68, S19-S19 (2018)
28.
Zhang, D.* et al.: Viral integration profiles in the plasma cell-free DNA from patients with HBV infection well represent tumor clone compositions during HCC development. J. Hepatol. 68, S121-S122 (2018)
29.
Michler, T. et al.: Preclinical study of a combinatorial RNAi/vaccination therapy as a potential cure for chronic hepatitis B. J. Hepatol. 66, S112-S112 (2017)
30.
Protzer, U.: Visualizing HEV infection in human liver tissue. J. Hepatol. 67, 471–479 (2017)
31.
Wisskirchen, K. et al.: Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV. J. Hepatol. 66, S29-S30 (2017)
32.
Xia, Y. et al.: Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. J. Hepatol. 66, 494-503 (2017)
33.
Blondot, M.L.* ; Bruss, V. & Kann, M.*: Intracellular transport and egress of hepatitis B virus. J. Hepatol. 64, S49-S59 (2016)
34.
Bohne, F. et al.: BI-and trispecific antibodyconstructs mediate specific TCell retargeting towards and elimination of HBV-positive hepatocytes and tumor cells. J. Hepatol. 64, S387-S387 (2016)
35.
Einer, C. et al.: Mitochondrial adaptation to high caloric challenge protects against fatty acid-induced hepatotoxicity but promotes liver steatosis in nash. J. Hepatol. 64, S684-S684 (2016)
36.
Hohenester, S.* et al.: Progression of non-alcoholic fatty liver disease towards steatohepatitis is differentially mediated by inflammasome-induced downstream pathways IL-1 and IL-18. J. Hepatol. 64, S683-S684 (2016)
37.
Karimzadeh, H. et al.: Correlation of mutations within HDV-protein with HLA Backgrounds of patients leads to identification of novel CD8 T cell epitopes. J. Hepatol. 64, S361-S361 (2016)
38.
Koppe, C.* et al.: Ikkalpha/beta regulate hepatocarcinogenesis and biliary homeostasis by controlling RIPK1 activity. J. Hepatol. 64, S312-S313 (2016)
39.
Kremer, L.S. et al.: Severe respiratory complex III defect prevents liver adaptation to prolonged fasting. J. Hepatol. 65, 377-385 (2016)
40.
Lucifora, J.* & Protzer, U.: Attacking hepatitis B virus cccDNA - the holy grail to hepatitis B cure. J. Hepatol. 64, S41-S48 (2016)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮